EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Aspirin hypersensitivity diagnostic index ( AHDI ): In vitro test for diagnosing of N‐ ERD based on urinary 15‐oxo‐ ETE and LTE 4 excretion

Lucyna Mastalerz iD, Gabriela Trąd, Piotr Szatkowski, Adam Ćmiel, Anna Gielicz iD, Radosław Kacorzyk, Hanna Plutecka, Joanna Szaleniec, Agnieszka Gawlewicz-Mroczka, Bogdan Jakieła, Marek Sanak iD

Allergy · 2025

DOI: 10.1111/all.16281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2025. Verfasst von Lucyna Mastalerz und 10 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland. Hauptthemen laut MEDLINE: Leukotriene E4, Aspirin, Drug Hypersensitivity, Asthma, Aspirin-Induced. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

15‐oxo‐eicosatetraenoic acid (15‐oxo‐ETE), is a product of arachidonic acid (AA) metabolism in the 15‐lipoxygenase‐1 (15‐LOX‐1) pathway. 15‐oxo‐ETE was overproduced in the nasal polyps of patients with nonsteroidal anti‐inflammatory drug–exacerbated respiratory disease (N‐ERD). In this study we investigated the systemic biosynthesis of 15‐oxo‐ETE and leukotriene E 4 (LTE 4 ) and assessed their diagnostic value to identify patients with N‐ERD.

Methods

The study included 64 patients with N‐ERD, 59 asthmatics who tolerated aspirin well (ATA), and 51 healthy controls. A thorough clinical characteristics of asthmatics included computed tomography of paranasal sinuses. Plasma and urinary 15‐oxo‐ETE levels, and urinary LTE 4 excretion were measured using high‐performance liquid chromatography and tandem mass spectrometry. Repeatability and precision of the measurements were tested.

Results

Plasma 15‐oxo‐ETE levels were the highest in N‐ERD ( p < .001). A receiver operator characteristic (ROC) revealed that 15‐oxo‐ETE had certain sensitivity (64.06% in plasma, or 88.24% in urine) for N‐ERD discrimination, while the specificity was rather limited. Modeling of variables allowed to construct the Aspirin Hypersensitivity Diagnostic Index (AHDI) based on urinary LTE 4 ‐to‐15‐oxo‐ETE excretion corrected for sex and the Lund‐Mackay score of chronic rhinosinusitis. AHDI outperformed single measurements in discrimination of N‐ERD among asthmatics with an area under ROC curve of 0.889, sensitivity of 81.97%, specificity of 87.23%, and accuracy of 86.87%.

Conclusions

We confirmed 15‐oxo‐ETE as a second to cysteinyl leukotrienes biomarker of N‐ERD. An index based on these eicosanoids corrected for sex and Lund‐Mackay score has a similar diagnostic value as gold standard oral aspirin challenge in the studied group of patients with asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukotriene E4AspirinDrug HypersensitivityAsthma, Aspirin-InducedArachidonic AcidsAnti-Inflammatory Agents, Non-SteroidalHumansMaleFemaleMiddle AgedAdultBiomarkersROC CurveAgedHydroxyeicosatetraenoic Acids

Stichwörter der Autor:innen

15‐oxo‐eicosatetraenoic acidNSAID‐exacerbated respiratory diseaseaspirin hypersensitivity diagnostic indexin‐vitro diagnostic test

Substanzen

Leukotriene E4AspirinBiomarkersArachidonic AcidsAnti-Inflammatory Agents, Non-Steroidal15-hydroxy-5,8,11,13-eicosatetraenoic acidHydroxyeicosatetraenoic Acids

Autor:innen und Institutionen

  • 2nd Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Doctoral School of Medical and Health Sciences, Jagiellonian University, Krakow, Poland.
  • Department of Applied Mathematics, AGH University of Science and Technology, Krakow, Poland.
  • Department of Otolaryngology, Jagiellonian University Medical College, Krakow, Poland.

ORCID-Profile: Lucyna Mastalerz, Anna Gielicz, Marek Sanak

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Mastalerz, L., Trąd, G., Szatkowski, P., Ćmiel, A., Gielicz, A., Kacorzyk, R., Plutecka, H., Szaleniec, J., Gawlewicz-Mroczka, A., Jakieła, B., & Sanak, M. (2025). Aspirin hypersensitivity diagnostic index ( AHDI ): In vitro test for diagnosing of N‐ ERD based on urinary 15‐oxo‐ ETE and LTE 4 excretion. Allergy. https://doi.org/10.1111/all.16281

Vancouver

Mastalerz L, Trąd G, Szatkowski P, Ćmiel A, Gielicz A, Kacorzyk R, et al. Aspirin hypersensitivity diagnostic index ( AHDI ): In vitro test for diagnosing of N‐ ERD based on urinary 15‐oxo‐ ETE and LTE 4 excretion. Allergy. 2025. doi:10.1111/all.16281

BibTeX
@article{Mastalerz2025,
  author = {Mastalerz, Lucyna and Trąd, Gabriela and Szatkowski, Piotr and Ćmiel, Adam and Gielicz, Anna and Kacorzyk, Radosław and Plutecka, Hanna and Szaleniec, Joanna and Gawlewicz-Mroczka, Agnieszka and Jakieła, Bogdan and Sanak, Marek},
  title = {Aspirin hypersensitivity diagnostic index ( AHDI ): In vitro test for diagnosing of N‐ ERD based on urinary 15‐oxo‐ ETE and LTE 4 excretion},
  journal = {Allergy},
  year = {2025},
  doi = {10.1111/all.16281}
}
Kostenlos starten →